Advantage Alpha Capital Partners’s Catalyst Pharmaceutical CPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$352K Sell
2025
Q1
$486K Buy
2024
Q4
$272K Sell
2024
Q3
$501K Sell
2024
Q2
$578K Buy